Australia Infection Control Market - Forecasts from 2020 to 2025
Australia infection control market is estimated to augment with a growth rate of 7.71% over the forecast period 2019-2025. The advanced healthcare system in Australia is projected to surge the growth of the infection control market in the country during the forecast period. The growing geriatric population and the growing prevalence of chronic diseases are propagating the market demand with the increasing number of visits for diagnosis, treatment and post-treatment care. Additionally, with advancements in medical research and innovations in the medical industry, the market is estimated to grow with a high growth rate in the forecast period. Furthermore, with the emergence of new technologies in healthcare, the country is geared towards the effective utilization of these novel technologies which will have a strong impact on the health of the Australian citizens and the medical services provided to these individuals. The novel technologies range from digital health technologies to automated health and diagnostic services, thus, impacting positively the growth of the infection control industry in the forecast period.
The presence of primary health networks (PHNs) in the country is propelling the market growth in the forecast period.
According to the Australian Government Department of Health, there are 31 primary health networks in the country. Primary health networks, PHNs are referred to organizations responsible for coordinating health services in the local areas of the country. These are known to support community health centers, hospitals, GPs, specialists, and other health professionals for the improvement of patient care. Also, these coordinate the different stages of the health system, examples include, the coordination between the hospital and the doctor at the time of patient discharge. PHNs are also involved in the assessment of the health needs of individuals in their local area. The provision of the extra services including after-hours services, mental health services, health promotion programs, and support for primary care (GPs) which include the continuing education is also providing an opportunity for the market to grow in the forecast period and in the upcoming years owing to the use of infection control products in several ongoing healthcare activities.
The growing medical research and innovation in Australia are driving the market demand in the forecast period and in the upcoming years.
Certain strategies including the Australian Medical Research and Innovation Strategy 2016-2021 are encouraging the growth of medical research and innovation in the country, hence, the infection control market is estimated to hold strong growth prospects to burgeon in the forecast period and in the coming years. The innovation strategy mentioned above designed by the Australian Medical Research Advisory Board is aimed towards achieving certain objectives through six platforms. These include strategic and international horizons, resulting in leading and collaborating with international health and medical research. The other platform including data and infrastructure deals in the integration of the health data framework for supporting healthcare delivery, service improvement, and adopting the best healthcare practices. Other platforms consist of capacity and collaboration, health services and systems, trials and translation, and commercialization, further providing an opportunity for the market to flourish in the forecast period and in the upcoming years.
Segmentation:
The presence of primary health networks (PHNs) in the country is propelling the market growth in the forecast period.
According to the Australian Government Department of Health, there are 31 primary health networks in the country. Primary health networks, PHNs are referred to organizations responsible for coordinating health services in the local areas of the country. These are known to support community health centers, hospitals, GPs, specialists, and other health professionals for the improvement of patient care. Also, these coordinate the different stages of the health system, examples include, the coordination between the hospital and the doctor at the time of patient discharge. PHNs are also involved in the assessment of the health needs of individuals in their local area. The provision of the extra services including after-hours services, mental health services, health promotion programs, and support for primary care (GPs) which include the continuing education is also providing an opportunity for the market to grow in the forecast period and in the upcoming years owing to the use of infection control products in several ongoing healthcare activities.
The growing medical research and innovation in Australia are driving the market demand in the forecast period and in the upcoming years.
Certain strategies including the Australian Medical Research and Innovation Strategy 2016-2021 are encouraging the growth of medical research and innovation in the country, hence, the infection control market is estimated to hold strong growth prospects to burgeon in the forecast period and in the coming years. The innovation strategy mentioned above designed by the Australian Medical Research Advisory Board is aimed towards achieving certain objectives through six platforms. These include strategic and international horizons, resulting in leading and collaborating with international health and medical research. The other platform including data and infrastructure deals in the integration of the health data framework for supporting healthcare delivery, service improvement, and adopting the best healthcare practices. Other platforms consist of capacity and collaboration, health services and systems, trials and translation, and commercialization, further providing an opportunity for the market to flourish in the forecast period and in the upcoming years.
Segmentation:
- By Product
- Disinfectant
- Sterilization
- Low temperature Sterilization
- Heat Sterilization
- Contract Sterilization
- By End User Industry
- Healthcare
- Food and Beverage
- Chemical
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. AUSTRALIA INFECTION CONTROL MARKET ANALYSIS, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. AUSTRALIA INFECTION CONTROL MARKET ANALYSIS, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. Sch?lke & Mayr GmbH
8.3. B. Braun Melsungen AG
8.4. Getinge AB
8.5. Franke Medical Oy
8.6. List is not Exhaustive*
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. AUSTRALIA INFECTION CONTROL MARKET ANALYSIS, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. AUSTRALIA INFECTION CONTROL MARKET ANALYSIS, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. Sch?lke & Mayr GmbH
8.3. B. Braun Melsungen AG
8.4. Getinge AB
8.5. Franke Medical Oy
8.6. List is not Exhaustive*
